Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients

Documenti analoghi

• The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
  di: van Damme, N, et al.
  Pubblicazione: (2002)
• Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
  di: De Rycke, L, et al.
  Pubblicazione: (2003)
• Sensitivity of ANA indirect immunofluorescence testing for the detection of anti-ENA antibodies
  di: Hoffman, IEA, et al.
  Pubblicazione: (2002)
• Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
  di: De Rycke, L, et al.
  Pubblicazione: (2005)
• Infliximab induced anti-dsDNA: characteristics of autoantibody response
  di: Charles, PJ, et al.
  Pubblicazione: (2002)